Thus, the detected high serum concentrations of IL-17, IL-18, and TNF-α in COPD, ACO, and BA may indicate the participation of these cytokines in the development of systemic inflammation in patients with these diseases. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.